It's been business as usual for drugmakers, with far more price hikes than cuts, analysis shows.
The Associated Press, Times Herald-Record
Mon, 09/24/2018 - 4:33pm
It's been business as usual for drugmakers, with far more price hikes than cuts, analysis shows.